(34), involving a cohort of 171 individuals divided into three categories—healthy individuals, individuals with pre-T2D, and patients with T2D—demonstrated a gradual increase in sclerostin levels and sclerostin mRNA expression from healthy to pre-T2D to T2D. The gene discussed is SOST; the disease is type 2 diabetes mellitus.